Differential Akt signalling in non-seminomatous testicular germ cell tumors

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3783-3788

  Hennenlotter, Joerg ^a   Amend, Bastian ^a   Vogel, Ulrich ^a   Renninger, Markus ^a   Pringer, Christine ^b   Kuehs, Ursula ^a   Stenzl, Arnulf ^a   Bedke, Jens ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Klin Diagn/Interventionelle R   (Germany)

Author keywords

Akt; Non seminomatous testicular cancer; p27 Kip1; PTEN; Subcellular distribution

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT; ARTICLE; BENIGN TESTICULAR PARENCHYMA; BENIGN TUMOR; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; EMBRYONAL CARCINOMA; ENZYME REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TERATOMA; YOLK SAC TUMOR;

ADULT; CARCINOMA, EMBRYONAL; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; ENDODERMAL SINUS TUMOR; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TERATOMA; TESTICULAR NEOPLASMS;

EID: 83055191350     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sirohi B and Huddart R: The management of poor-prognosis, non-seminomatous germ-cell tumours. Clin Oncol (R Coll Radiol) 17(7): 543-552, 2005. (Pubitemid 41350122)
2. Berz D and Wanebo H: Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors. J Surg Oncol 103(6): 574-586, 2011.
3. Kollmannsberger CK, Oechsle K, Cheng T, Mayer F, Czaykowski P, Winquist E, Wood L, Fenner M, Chi KN and Bokemeyer C: Sunitinib in patients with multiple relapsed or cisplatin-refractory germ cell cancer: A CUOG/GTCSG cooperative phase II study. J Clin Oncol 28(7:s): (suppl; abstr 4582), 2010.
4. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X and Figlin RA: Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27(22): 3584-3590, 2009.
5. Di Vizio D, Cito L, Boccia A, Chiefft P, Insabato L, Pettinato G, Motti ML, Schepis F, D'Amico W, Fabiani F, Tavernise B, Venuta S, Fusco A and Viglietto G: Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24(11): 1882-1894, 2005. (Pubitemid 40462790)
6. Theodorescu D, Broder SR, Boyd JC, Mills SE and Frierson HF Jr.: Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 80(11): 2109-2119, 1997. (Pubitemid 27506024)
7. Merseburger AS, Hennenlotter J, Simon P, Muller CC, Kuhs U, Knuchel-Clarke R, Moul JW, Stenzl A and Kuczyk MA: Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions. Oncol Rep 16(1): 79-83, 2006.
8. Hollander MC, Blumenthal GM and Dennis PA: PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11(4): 289-301, 2011.
9. Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, Ikeuchi M, Nagy A, Mak TW and Nakano T: Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130(8): 1691-1700, 2003. (Pubitemid 36527527)
10. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE and Bartek J: Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 85(3): 370-375, 2000. (Pubitemid 30030411)
11. Kip1 are not downregulated in the majority of renal cell carcinomas - implications for Akt activation. Oncol Rep 19(5): 1141-1147, 2008.
12. Mundhenk J, Hennenlotter J, Zug L, Alloussi SH, Todenhoefer T, Gakis G, Aufderklamm S, Scharpf M, Kuehs U, Stenzl A and Schwentner C: Evidence for a PTEN-independent Akt activation and Akt independent p27(Kip1) expression in advanced bladder cancer. Oncol Lett 6(2): 1089-1093, 2011.
13. Planchon SM, Waite KA and Eng C: The nuclear affairs of PTEN. J Cell Sci 121(Pt 3): 249-253, 2008. (Pubitemid 351356695)
14. Pandolfi PP: P-TEN exciting years: from the cytosol to the nucleus and back to keep cancer at bay. Oncogene 27(41): 5386, 2008.
15. Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J and Yung WK: Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 67(22): 11054-11063, 2007. (Pubitemid 350145936)
16. Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR and Wu H: PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 28(10): 3281-3289, 2008. (Pubitemid 351657092)
17. Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Midgley CA and Lane DP: p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 49(2): 196-202, 1991.
18. Blain SW and Massague J: Breast cancer banishes p27 from nucleus. Nat Med 8(10): 1076-1078, 2002. (Pubitemid 35175956)
19. Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J and Arteaga CL: Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 66(4): 2162-2172, 2006.
20. Viglietto G, Motti ML and Fusco A: Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 1(6): 394-400, 2002.
21. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E and Slingerland JM: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8(10): 1153-1160, 2002. (Pubitemid 35175971)
22. Hidaka T, Hama S, Shrestha P, Saito T, Kajiwara Y, Yamasaki F, Sugiyama K and Kurisu K: The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Anticancer Res 29(2): 597-603, 2009.
23. Moe-Behrens GH, Klinger FG, Eskild W, Grotmol T, Haugen TB and De Felici M: Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 17(12): 2630-2638, 2003. (Pubitemid 37542223)
24. Nakai Y, Nonomura N, Oka D, Shiba M, Arai Y, Nakayama M, Inoue H, Nishimura K, Aozasa K, Mizutani Y, Miki T and Okuyama A: KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. Biochem Biophys Res Commun 337(1): 289-296, 2005. (Pubitemid 41393792)
25. Chieffi P: Molecular targets for the treatment of testicular germ cell tumors. Mini Rev Med Chem 7(7): 755-759, 2007.
26. Oechsle K, Honecker F, Cheng T, Mayer F, Czaykowski P, Winquist E, Wood L, Fenner M, Glaesener S, Hartmann JT, Chi K, Bokemeyer C and Kollmannsberger C: Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. Ann Oncol in press (2011).
27. McIntyre A, Gilbert D, Goddard N, Looijenga L and Shipley J: Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults. Genes Chromosomes Cancer 47(7): 547-557, 2008. (Pubitemid 351748341)